Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health (NIH) is an agency operating within the Department of Human Health and Services and is responsible for the country's bio-medical and health-related research studies.

The NIH's efforts are mainly focused on obtaining new information to help prevent, detect, diagnose and treat a wide range of diseases and disabilities, all in the hopes of uncovering new knowledge that will lead to a better health for all.

In keeping with its goals and objectives, NIH has recently established a program entitled Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments.

The goal of the Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments program is to be able to seek high-quality, health economics research ancillary to large-scale federal and non-federal pilots, demonstrations, other experiments in areas of health care payment, structure, or health care organization that are currently seeking approaches that would reduce costs while simultaneously enhancing quality and outcomes.

As emphasized in the program's official announcement, the types of research that are encouraged may include:

a) Research studies that would boost the scientific yield of completed or ongoing Pilots, Demonstrations, and Other Experiments (PDEs)

b) Research studies that would improve the scientific yield of multi-site PDEs

c) Research studies that would formally test the effect of costs, quality, and patient outcomes of PDEs that have been the subject of less rigorous analyses.

  (continued...)

Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---

Mobile Health Tools to Promote Effective Patient Provider Communication to Underserved Populations
The National Institute of Nursing Research, in cooperation with the Office of Dietary Supplements has constituted the funding opportunity for Mobile Health tools aimed at the improvement of effective patient-provider communication, adherence to treatment and self-management of chronic diseases in underserved populations.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---